FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2608524881> ?p ?o ?g. }

• W2608524881 endingPage "136" @default.
• W2608524881 startingPage "130" @default.
• W2608524881 abstract "Interferon-based regimens for chronic hepatitis C (CHC) were often deferred in patients with β-thalasaemia major (β-TM) due to poor efficacy and tolerance. Current guidelines recommend direct-acting antivirals (DAAs) for these patients. The aim of this study was to assess the safety and efficacy of DAAs in patients with β-TM and advanced liver disease due to CHC. Patients were recruited from eight liver units in Greece. The stage of liver disease was assessed using transient elastography and/or liver histology. Five regimens were used: sofosbuvir (SOF) + ribavirin (RBV); SOF + simeprevir ± RBV; SOF + daclatasvir ± RBV; ledipasvir/SOF ± RBV and ombitasvir/paritaprevir-ritonavir + dasabuvir ± RBV. Sixty-one patients (median age 43 years) were included. The majority of patients was previously treated for hepatitis C (75%) and had cirrhosis (79%). Viral genotype distribution was: G1a: n = 10 (16%); G1b: n = 22 (36%); G2: n = 2 (3%); G3: n = 14 (23%); G4: n = 13 (22%). The predominant chelation therapy was a combination of deferoxamine and deferiprone (35%). Overall sustained virological response rates were 90%. All treatment regimens were well tolerated and no major adverse events or drug-drug interactions were observed. Approximately half of the patients who received RBV (7/16, 44%) had increased needs for blood transfusion. Treatment of CHC with DAAs in patients with β-TM and advanced liver disease was highly effective and safe." @default.
• W2608524881 created "2017-05-05" @default.
• W2608524881 creator A5008950143 @default.
• W2608524881 creator A5009238813 @default.
• W2608524881 creator A5013316530 @default.
• W2608524881 creator A5013679002 @default.
• W2608524881 creator A5016225212 @default.
• W2608524881 creator A5021164432 @default.
• W2608524881 creator A5030128305 @default.
• W2608524881 creator A5034834044 @default.
• W2608524881 creator A5035672837 @default.
• W2608524881 creator A5039121249 @default.
• W2608524881 creator A5050730270 @default.
• W2608524881 creator A5053053769 @default.
• W2608524881 creator A5060859912 @default.
• W2608524881 creator A5065856431 @default.
• W2608524881 creator A5069334549 @default.
• W2608524881 creator A5072112983 @default.
• W2608524881 creator A5077245179 @default.
• W2608524881 creator A5080574572 @default.
• W2608524881 creator A5083059375 @default.
• W2608524881 creator A5083845265 @default.
• W2608524881 creator A5086368765 @default.
• W2608524881 date "2017-04-25" @default.
• W2608524881 modified "2023-10-05" @default.
• W2608524881 title "Treatment of chronic hepatitis C with direct-acting antivirals in patients with β-thalassaemia major and advanced liver disease" @default.
• W2608524881 cites W1967657836 @default.
• W2608524881 cites W1980154502 @default.
• W2608524881 cites W1980771473 @default.
• W2608524881 cites W1986691787 @default.
• W2608524881 cites W1990539469 @default.
• W2608524881 cites W2013147383 @default.
• W2608524881 cites W2019157254 @default.
• W2608524881 cites W2026576562 @default.
• W2608524881 cites W2069465518 @default.
• W2608524881 cites W2074918898 @default.
• W2608524881 cites W2085147002 @default.
• W2608524881 cites W2095178021 @default.
• W2608524881 cites W2113636405 @default.
• W2608524881 cites W2134346205 @default.
• W2608524881 cites W2140996066 @default.
• W2608524881 cites W2162811579 @default.
• W2608524881 cites W2169936170 @default.
• W2608524881 cites W2289667014 @default.
• W2608524881 cites W2290493078 @default.
• W2608524881 cites W2317627985 @default.
• W2608524881 cites W2320330796 @default.
• W2608524881 cites W2442410340 @default.
• W2608524881 cites W2523333062 @default.
• W2608524881 cites W4211243282 @default.
• W2608524881 doi "https://doi.org/10.1111/bjh.14640" @default.
• W2608524881 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28439915" @default.
• W2608524881 hasPublicationYear "2017" @default.
• W2608524881 type Work @default.
• W2608524881 sameAs 2608524881 @default.
• W2608524881 citedByCount "22" @default.
• W2608524881 countsByYear W26085248812018 @default.
• W2608524881 countsByYear W26085248812019 @default.
• W2608524881 countsByYear W26085248812020 @default.
• W2608524881 countsByYear W26085248812021 @default.
• W2608524881 countsByYear W26085248812022 @default.
• W2608524881 countsByYear W26085248812023 @default.
• W2608524881 crossrefType "journal-article" @default.
• W2608524881 hasAuthorship W2608524881A5008950143 @default.
• W2608524881 hasAuthorship W2608524881A5009238813 @default.
• W2608524881 hasAuthorship W2608524881A5013316530 @default.
• W2608524881 hasAuthorship W2608524881A5013679002 @default.
• W2608524881 hasAuthorship W2608524881A5016225212 @default.
• W2608524881 hasAuthorship W2608524881A5021164432 @default.
• W2608524881 hasAuthorship W2608524881A5030128305 @default.
• W2608524881 hasAuthorship W2608524881A5034834044 @default.
• W2608524881 hasAuthorship W2608524881A5035672837 @default.
• W2608524881 hasAuthorship W2608524881A5039121249 @default.
• W2608524881 hasAuthorship W2608524881A5050730270 @default.
• W2608524881 hasAuthorship W2608524881A5053053769 @default.
• W2608524881 hasAuthorship W2608524881A5060859912 @default.
• W2608524881 hasAuthorship W2608524881A5065856431 @default.
• W2608524881 hasAuthorship W2608524881A5069334549 @default.
• W2608524881 hasAuthorship W2608524881A5072112983 @default.
• W2608524881 hasAuthorship W2608524881A5077245179 @default.
• W2608524881 hasAuthorship W2608524881A5080574572 @default.
• W2608524881 hasAuthorship W2608524881A5083059375 @default.
• W2608524881 hasAuthorship W2608524881A5083845265 @default.
• W2608524881 hasAuthorship W2608524881A5086368765 @default.
• W2608524881 hasBestOaLocation W26085248811 @default.
• W2608524881 hasConcept C126322002 @default.
• W2608524881 hasConcept C142462285 @default.
• W2608524881 hasConcept C159047783 @default.
• W2608524881 hasConcept C2522874641 @default.
• W2608524881 hasConcept C2775999097 @default.
• W2608524881 hasConcept C2776408679 @default.
• W2608524881 hasConcept C2776455275 @default.
• W2608524881 hasConcept C2776461080 @default.
• W2608524881 hasConcept C2776979040 @default.
• W2608524881 hasConcept C2777075537 @default.
• W2608524881 hasConcept C2777100407 @default.
• W2608524881 hasConcept C2778159067 @default.
• W2608524881 hasConcept C2778390639 @default.

• next